Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franka Menge

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Cancer Research and Clinical Oncology|May 18, 2026
Evaluating reasoning models for therapy recommendations in gastrointestinal stromal tumors: expert and LLM-based evaluations of OpenAI o1 and DeepSeek-R1Melissa Harbrücker, Franka Menge, Arshia Taebi, et al.
BMC Cancer|January 12, 2026
Evaluation of magnetic resonance imaging parameters and compliance with guidelines in soft tissue sarcomasMadelaine Hettler, Josephine Kirschstein, Isabelle Ayx, et al.
Journal of Cancer Research and Clinical Oncology|September 9, 2025
The imitation game: large language models versus multidisciplinary tumor boards: benchmarking AI against 21 sarcoma centers from the ring trialCheng-Peng Li, Aimé Terence Kalisa, Siyer Roohani, et al.
BMJ Open|December 30, 2025
Multicentre prospective non-interventional study protocol for evaluating surgical strategies for Colorectal Resections and Postoperative Quality of Life in Retroperitoneal Sarcoma Patients Across German-Speaking Sarcoma Centres (COLOSARC-Q)Madelaine Hettler, Katrin R Scharpf, Anna Eich, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 23, 2026
Evidence-based quality indicators of soft tissue sarcomas in Germany 2015-2021: An analysis of the German Cancer Registry GroupFrank Goßmann, Nikola Beck, Jens Jakob, et al.
Journal of Cancer Research and Clinical Oncology|April 21, 2026
Treatment of retroperitoneal sarcoma in Germany between 2000 and 2022: a retrospective analysis from the German Cancer Registry GroupNikola Beck, Frank Goßmann, Peter Hohenberger, et al.
European Journal of Cancer Care|August 3, 2021
Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa)Martin Eichler, Daniel Pink, Franka Menge, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2020
Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'Patrick Schöffski, Olivier Mir, Bernd Kasper, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Cancer Research and Clinical Oncology|May 18, 2026
Evaluating reasoning models for therapy recommendations in gastrointestinal stromal tumors: expert and LLM-based evaluations of OpenAI o1 and DeepSeek-R1Melissa Harbrücker, Franka Menge, Arshia Taebi, et al.
BMC Cancer|January 12, 2026
Evaluation of magnetic resonance imaging parameters and compliance with guidelines in soft tissue sarcomasMadelaine Hettler, Josephine Kirschstein, Isabelle Ayx, et al.
Journal of Cancer Research and Clinical Oncology|September 9, 2025
The imitation game: large language models versus multidisciplinary tumor boards: benchmarking AI against 21 sarcoma centers from the ring trialCheng-Peng Li, Aimé Terence Kalisa, Siyer Roohani, et al.
BMJ Open|December 30, 2025
Multicentre prospective non-interventional study protocol for evaluating surgical strategies for Colorectal Resections and Postoperative Quality of Life in Retroperitoneal Sarcoma Patients Across German-Speaking Sarcoma Centres (COLOSARC-Q)Madelaine Hettler, Katrin R Scharpf, Anna Eich, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 23, 2026
Evidence-based quality indicators of soft tissue sarcomas in Germany 2015-2021: An analysis of the German Cancer Registry GroupFrank Goßmann, Nikola Beck, Jens Jakob, et al.
Journal of Cancer Research and Clinical Oncology|April 21, 2026
Treatment of retroperitoneal sarcoma in Germany between 2000 and 2022: a retrospective analysis from the German Cancer Registry GroupNikola Beck, Frank Goßmann, Peter Hohenberger, et al.
European Journal of Cancer Care|August 3, 2021
Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa)Martin Eichler, Daniel Pink, Franka Menge, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2020
Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'Patrick Schöffski, Olivier Mir, Bernd Kasper, et al.
Pageof 2